Combination antiretroviral therapy and recent declines in AIDS incidence and mortality.
about
Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studiesLatent reservoirs of HIV: obstacles to the eradication of virusOral manifestations in the era of HAARTPrevention strategies for blood-borne viruses-in the Era of vaccines, direct acting antivirals and antiretroviral therapyEpidemiology, clinical characteristics and outcomes of extensively drug-resistant Acinetobacter baumannii infections among solid organ transplant recipientsHIV-1 Genetic Variability and Clinical ImplicationsUse of silver nanoparticles increased inhibition of cell-associated HIV-1 infection by neutralizing antibodies developed against HIV-1 envelope proteinsIn vitro antiviral activity and cross-resistance profile of PL-100, a novel protease inhibitor of human immunodeficiency virus type 1Species distribution and in vitro antifungal susceptibility of oral yeast isolates from Tanzanian HIV-infected patients with primary and recurrent oropharyngeal candidiasisHepatic profile analyses of tipranavir in Phase II and III clinical trialsEffects of intermittent IL-2 alone or with peri-cycle antiretroviral therapy in early HIV infection: the STALWART studyPros and cons of liver transplantation in human immunodeficiency virus infected recipients.Regional variations in HIV disclosure in Thailand: implications for future interventions.Prevalence and risk factors of poor immune recovery among adult HIV patients attending care and treatment centre in northwestern Tanzania following the use of highly active antiretroviral therapy: a retrospective study.Risky sexual practices and related factors among ART attendees in Addis Ababa Public Hospitals, Ethiopia: a cross-sectional study.Recent key advances in human immunodeficiency virus medicine and implications for ChinaReproductive assistance in HIV serodiscordant couples.A multicenter study of initiation of antiretroviral therapy and transmitted drug resistance in antiretroviral-naive adolescents and young adults with HIV in New York CityDevelopment of immunotherapeutic strategies for HIV-1.Candidate vaccines for immunotherapy in HIV.Smoking and life expectancy among HIV-infected individuals on antiretroviral therapy in Europe and North America.Scaling up antiretroviral treatment services in Karnataka, India: impact on CD4 counts of HIV-infected people.Challenges and changing roles in HIV/AIDS social work: implications for training and education.HIV viral suppression in the era of antiretroviral therapyEvaluation of atazanavir and darunavir interactions with lipids for developing pH-responsive anti-HIV drug combination nanoparticlesMortality trends in the US Perinatal AIDS Collaborative Transmission Study (1986-2004)Barriers to antiretroviral initiation in HIV-1-discordant couples.HIV prevention in the era of new treatments.A quantitative risk assessment of multiple factors influencing HIV/AIDS transmission through unprotected sex among HIV-seropositive menManagement of protozoa-related diarrhea in HIV infection.Commentary: Questioning the HIV-AIDS Hypothesis: 30 Years of DissentThe effect of injecting drug use history on disease progression and death among HIV-positive individuals initiating combination antiretroviral therapy: collaborative cohort analysis.Facilitators and Barriers of Antiretroviral Therapy Initiation among HIV Discordant Couples in Kenya: Qualitative Insights from a Pre-Exposure Prophylaxis Implementation Study.Polymorphism and drug-selected mutations in the protease gene of human immunodeficiency virus type 2 from patients living in Southern France.Directly observed versus self-administered antiretroviral therapies: preference of HIV-positive jailed inmates in San Francisco.Performance of creatinine and cystatin C GFR estimating equations in an HIV-positive population on antiretrovirals.Can highly active antiretroviral therapy reduce the spread of HIV?: A study in a township of South Africa.Predictors of unsafe sexual behavior among people living with human immunodeficiency virus/AIDS attending antiretroviral therapy center in Western India.Incidence and outcomes of malignancy in the HAART era in an urban cohort of HIV-infected individuals.Azido-containing diketo acid derivatives inhibit human immunodeficiency virus type 1 integrase in vivo and influence the frequency of deletions at two-long-terminal-repeat-circle junctions.
P2860
Q24597052-6E51B9E3-CAF3-4FA7-80A0-1F91DB73D03DQ24615570-D9D3888C-0562-4FEF-BC39-958956568D56Q24651801-48661CE7-325E-4C8C-8C57-A83278804805Q28076466-4DF43AFD-4F0B-4393-9EE2-8DC5811A6039Q28484482-3EE3DB47-40F9-4749-9206-A30B8FC1AF7AQ30352010-0445E5CF-A371-4A03-B9F0-3AB5F1DABEB5Q30407161-C146435E-846D-4549-9690-D69715DC26DDQ33291158-C2C26382-8CD6-4B1A-820D-2B7611DD1DEBQ33359301-8331A3FE-00E4-4F7C-91D3-C2AE5D1C0781Q33518011-C75AC6B2-F2C2-4BC9-83F1-BBFFE76195D6Q33534648-4906A353-309B-4644-B410-2E1B6A96ED80Q33594879-430B571C-C5F3-4CAD-A445-5ED76578F453Q33718830-38996E1B-2D2C-487C-8C5E-CAC364C5F5E2Q33781469-9EEEFCCC-F137-46E3-9322-722DEF85B6BBQ33919220-C31E2A70-0F23-4FA7-91CB-DB0E5AF2BDCFQ33933502-BD286E3D-2C9F-4747-B397-D49D56CA712DQ34311329-6581B2B1-72A3-4753-B2CD-6AF8CDE9A11FQ34398159-8BF47D59-E8AB-4332-B6C6-491F9B38193CQ34452629-A7E79524-20A3-4B2A-AE57-0533F9C85DCFQ34459435-6A23298A-FB0A-4DEB-B2F0-1CB6562F8E66Q34823231-C0D6727A-FFAC-40A4-A220-707EBC736220Q34951296-88BA6186-E2C2-4F54-BD6C-47C177943B43Q34993660-A3ADF7C1-9C5A-41BF-BF5A-E7E7207C0871Q35059337-07083EE3-909E-4AE4-AE70-2F2C166EDEB2Q35147145-C444076A-5D60-422E-9459-760618D512B6Q35452217-B40AE001-709F-4B08-A7F7-4916F2E89781Q35452737-D69E58F7-FB92-48E2-AA85-FADC97875587Q35581199-AA45A558-4A83-4CA8-B297-AC386F27B55BQ35641865-F0261711-7A47-4471-8DF2-CE928BD93CC9Q35917249-D02D87FE-CF07-4D39-BCC3-9873423AC2E7Q35925705-0A4FC7FC-B47E-4B09-B599-0D62F1F2B6F1Q35962516-DDDBBB6B-27F9-4278-8BE8-816AA13DE028Q36216291-4E7E7313-23DA-48BC-A6F8-8F24D5616422Q36239954-D067BCD6-542D-4163-A527-17356ECCEC2EQ36293125-AF9019EB-C35A-45F4-BB36-734B4D3E2CD3Q36687721-EEAD3CED-9DBE-4458-8697-DC4069BCFA41Q36849824-6C2CD7B6-A5B2-498F-8332-A550CD122CDCQ36872493-D5BB0663-DC51-4B34-A0A8-4756A4F75B4BQ36908566-6FC78816-070E-42E5-8B57-2D7A7E14D6D5Q37009146-A49F95D7-DE48-4436-93F0-383941BFC190
P2860
Combination antiretroviral therapy and recent declines in AIDS incidence and mortality.
description
1999 nî lūn-bûn
@nan
1999 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի մարտին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Combination antiretroviral therapy and recent declines in AIDS incidence and mortality.
@ast
Combination antiretroviral therapy and recent declines in AIDS incidence and mortality.
@en
Combination antiretroviral therapy and recent declines in AIDS incidence and mortality.
@nl
type
label
Combination antiretroviral therapy and recent declines in AIDS incidence and mortality.
@ast
Combination antiretroviral therapy and recent declines in AIDS incidence and mortality.
@en
Combination antiretroviral therapy and recent declines in AIDS incidence and mortality.
@nl
prefLabel
Combination antiretroviral therapy and recent declines in AIDS incidence and mortality.
@ast
Combination antiretroviral therapy and recent declines in AIDS incidence and mortality.
@en
Combination antiretroviral therapy and recent declines in AIDS incidence and mortality.
@nl
P2093
P356
P1476
Combination antiretroviral therapy and recent declines in AIDS incidence and mortality.
@en
P2093
Buchbinder SP
Holmberg SD
O'Malley P
Vittinghoff E
P304
P356
10.1086/314623
P407
P577
1999-03-01T00:00:00Z